News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|August 10, 2011

Outpatient Hysteroscopy: Quality Survey in a District General Hospital

Author(s)OBGYN.net Staff

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Q+A: Fiona Baker, PhD, on sleep disturbances in menopause and the role of vasomotor symptoms

Q+A: Fiona Baker, PhD, on sleep disturbances in menopause and the role of vasomotor symptoms

ByFiona C. Baker, PhD,Joshua Fitch, Senior Editor

June 20th 2026

FDA: Levonorgestrel/ethinyl estradiol birth control patch sees update to labeled strength

FDA: Levonorgestrel/ethinyl estradiol birth control patch sees update to labeled strength

ByJoshua Fitch, Senior Editor

June 19th 2026

Depressed woman awake in the night | Image Credit: © StockPhotoPro - stock.adobe.com

Sleep disturbance and VMS are independently tied to reduced HRQoL

ByBenjamin P. Saylor

June 19th 2026

Spotlighting menopause and mental health with Jessica Gaulton, MD, MPH

Spotlighting menopause and mental health with Jessica Gaulton, MD, MPH

ByJessica Gaulton, MD, MPH

June 18th 2026

Interpreting elinzanetant data and benefits on sleep in postmenopausal women

Interpreting elinzanetant data and benefits on sleep in postmenopausal women

ByFiona C. Baker, PhD,Joshua Fitch, Senior Editor

June 18th 2026

Latest CME

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

NIRVANA: Elinzanetant cuts objective wakefulness in menopausal women

Multi-modality impact of elinzanetant's effect on postmenopausal sleep disturbance

FDA approves tebipenem pivoxil as first oral carbapenem antibiotic for complicated urinary tract infections

Q+A: Fiona Baker, PhD, on sleep disturbances in menopause and the role of vasomotor symptoms

FDA: Levonorgestrel/ethinyl estradiol birth control patch sees update to labeled strength